세계의 이식형 의료기기 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global market for implantable medical devices. The report provides an in-depth analysis of essential market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Implantable Medical Devices Market Size (2024E): US$126.3 Bn
• Projected Market Value (2031F): US$146.81 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 6.8%

Implantable Medical Devices Market - Report Scope:

Implantable medical devices are essential for treating various chronic conditions, including cardiovascular diseases, neurological disorders, and orthopedic issues. These devices are surgically inserted into the body to support or replace damaged tissues and organs. The market encompasses a wide range of products, including pacemakers, cochlear implants, dental implants, and orthopedic implants. The growth of this market is driven by the increasing prevalence of chronic diseases, advancements in device technology, and rising healthcare expenditure, which contribute to the growing demand for innovative and effective implantable solutions.

Market Growth Drivers:

The global implantable medical devices market is driven by several key factors, including the rising prevalence of chronic diseases such as heart disease, diabetes, and osteoarthritis. Technological advancements, such as the development of minimally invasive surgical techniques and smart implantable devices, are enhancing patient outcomes and comfort. The aging global population is also contributing to market growth, as older adults are more likely to require implantable devices for managing health conditions. Additionally, increasing investments in healthcare infrastructure and research and development activities are fueling innovation and expanding market opportunities.

Market Restraints:

Despite its promising growth prospects, the implantable medical devices market faces challenges related to high costs, stringent regulatory requirements, and potential complications associated with surgical procedures. The high cost of advanced implantable devices may limit their accessibility in low-income regions, creating barriers to market penetration. Regulatory hurdles, including lengthy approval processes and compliance with safety standards, can delay the introduction of new products. Furthermore, concerns about device-related infections, complications, and the need for revision surgeries may impact patient acceptance and market growth.

Market Opportunities:

The implantable medical devices market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient management and adherence to treatment. Emerging fields like bioelectronic medicine and regenerative medicine offer new avenues for developing advanced implantable solutions. Strategic partnerships, investment in R&D, and the expansion of product portfolios to address unmet medical needs are crucial for capitalizing on these opportunities and maintaining competitive advantage in the dynamic implantable devices landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the implantable medical devices market globally?
• Which device types and applications are contributing to the expansion of implantable medical devices in various healthcare settings?
• How are technological advancements reshaping the competitive landscape of the implantable medical devices market?
• Who are the key players in the implantable medical devices market, and what strategies are they employing to stay relevant?
• What are the emerging trends and future prospects in the global implantable medical devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global implantable medical devices market, including Medtronic plc, Boston Scientific Corporation, and Edwards Lifesciences Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop cutting-edge implantable solutions, such as advanced pacemakers, next-generation stents, and smart orthopedic implants. Collaborations with healthcare providers, medical device distributors, and research institutions facilitate market access and promote technology adoption. Emphasis on clinical trials, evidence-based practice, and patient-centered care enhances market growth and patient outcomes in the rapidly evolving implantable devices sector.

Key Companies Profiled:

• Medtronic plc
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Abbott Laboratories
• Stryker Corporation
• Cochlear Limited
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Johnson & Johnson
• B. Braun Melsungen AG

Implantable Medical Devices Market Segmentation

By Product

• Cardiovascular Implants
• Orthopedic Implants
• Ophthalmology Implants
• Dental Implants
• Aesthetic Implants
• Neurology Implants

By Biomaterial

• Ceramic
• Metallic
• Polymers
• Natural

By Region

• North America
• Latin America
• Europe
• South Asia & Oceania
• East Asia
• The Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Implantable Medical Devices Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Implantable Medical Devices Adoption / Usage Analysis, By Region
• 2.4. PESTLE Analysis
• 2.5. Key Regulations by Region
• 2.6. Porter Five Force's Analysis
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview

3. Price Trend Analysis, 2019-2024

• 3.1. Key Highlights
• 3.2. Key Factors Impacting Product Type Prices
• 3.3. Prices By Product Type
• 3.4. Regional Prices and Product Preferences

4. Global Implantable Medical Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 4.1. Key Highlights
  • 4.1.1. Market Value (US$ in Bn) Projections
  • 4.1.2. Market Size and Y-o-Y Growth
  • 4.1.3. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size Analysis, 2019-2023
  • 4.2.2. Current Market Size Forecast, 2024-2031
• 4.3. Global Implantable Medical Devices Market Outlook: Product Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) and Volume (Units) and Analysis by Product Type, 2019-2023
  • 4.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast by Product Type, 2024-2031
    • 4.3.3.1. Orthopedic Implants
    • 4.3.3.2. Cardiovascular Implants
    • 4.3.3.3. Stents
    • 4.3.3.4. Stent-related Implants
    • 4.3.3.5. Structural Cardiac Implants
    • 4.3.3.6. Spinal Implants
    • 4.3.3.7. Neurostimulators
    • 4.3.3.8. Ophthalmic Implants
    • 4.3.3.9. Dental Implants
    • 4.3.3.10. Facial Implants
    • 4.3.3.11. Breast Implants
• 4.4. Market Attractiveness Analysis: Product Type
• 4.5. Global Implantable Medical Devices Market Outlook: Biomaterial Type
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis by Biomaterial Type, 2019-2023
  • 4.5.3. Current Market Size (US$ Bn) Forecast by Biomaterial Type, 2024-2031
    • 4.5.3.1. Metallic Biomaterials
    • 4.5.3.2. Ceramic Biomaterials
    • 4.5.3.3. Polymers Biomaterials
    • 4.5.3.4. Natural Biomaterials
• 4.6. Market Attractiveness Analysis: Biomaterial Type

5. Global Implantable Medical Devices Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
• 5.3. Current Market Size (US$ Bn) Forecast by Region, 2024-2031
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Implantable Medical Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
  • 6.2.1. By Country
  • 6.2.2. By Product Type
  • 6.2.3. By Biomaterial Type
• 6.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Product Type, 2024-2031
  • 6.4.1. Orthopedic Implants
  • 6.4.2. Cardiovascular Implants
  • 6.4.3. Stents
  • 6.4.4. Stent-related Implants
  • 6.4.5. Structural Cardiac Implants
  • 6.4.6. Spinal Implants
  • 6.4.7. Neurostimulators
  • 6.4.8. Ophthalmic Implants
  • 6.4.9. Dental Implants
  • 6.4.10. Facial Implants
  • 6.4.11. Breast Implants
• 6.5. Current Market Size (US$ Bn) Forecast by Biomaterial Type, 2024-2031
  • 6.5.1. Metallic Biomaterials
  • 6.5.2. Ceramic Biomaterials
  • 6.5.3. Polymers Biomaterials
  • 6.5.4. Natural Biomaterials
• 6.6. Market Attractiveness Analysis

7. Europe Implantable Medical Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
  • 7.2.1. By Country
  • 7.2.2. By Product Type
  • 7.2.3. By Biomaterial Type
• 7.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
  • 7.3.1. Germany
  • 7.3.2. Italy
  • 7.3.3. France
  • 7.3.4. U.K.
  • 7.3.5. Turkey
  • 7.3.6. Russia
  • 7.3.7. Rest of Europe
• 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Product Type, 2024-2031
  • 7.4.1. Orthopedic Implants
  • 7.4.2. Cardiovascular Implants
  • 7.4.3. Stents
  • 7.4.4. Stent-related Implants
  • 7.4.5. Structural Cardiac Implants
  • 7.4.6. Spinal Implants
  • 7.4.7. Neurostimulators
  • 7.4.8. Ophthalmic Implants
  • 7.4.9. Dental Implants
  • 7.4.10. Facial Implants
  • 7.4.11. Breast Implants
• 7.5. Current Market Size (US$ Bn) Forecast by Biomaterial Type, 2024-2031
  • 7.5.1. Metallic Biomaterials
  • 7.5.2. Ceramic Biomaterials
  • 7.5.3. Polymers Biomaterials
  • 7.5.4. Natural Biomaterials
• 7.6. Market Attractiveness Analysis

8. Asia Pacific Implantable Medical Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
  • 8.2.1. By Country
  • 8.2.2. By Product Type
  • 8.2.3. By Biomaterial Type
• 8.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
  • 8.3.4. India
  • 8.3.5. Southeast Asia
  • 8.3.6. Rest of Asia Pacific
• 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Product Type, 2024-2031
  • 8.4.1. Orthopedic Implants
  • 8.4.2. Cardiovascular Implants
  • 8.4.3. Stents
  • 8.4.4. Stent-related Implants
  • 8.4.5. Structural Cardiac Implants
  • 8.4.6. Spinal Implants
  • 8.4.7. Neurostimulators
  • 8.4.8. Ophthalmic Implants
  • 8.4.9. Dental Implants
  • 8.4.10. Facial Implants
  • 8.4.11. Breast Implants
• 8.5. Current Market Size (US$ Bn) Forecast by Biomaterial Type, 2024-2031
  • 8.5.1. Metallic Biomaterials
  • 8.5.2. Ceramic Biomaterials
  • 8.5.3. Polymers Biomaterials
  • 8.5.4. Natural Biomaterials
• 8.6. Market Attractiveness Analysis

9. Latin America Implantable Medical Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
  • 9.2.1. By Country
  • 9.2.2. By Product Type
  • 9.2.3. By Biomaterial Type
• 9.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Argentina
  • 9.3.4. Rest of Latin America
• 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Product Type, 2024-2031
  • 9.4.1. Orthopedic Implants
  • 9.4.2. Cardiovascular Implants
  • 9.4.3. Stents
  • 9.4.4. Stent-related Implants
  • 9.4.5. Structural Cardiac Implants
  • 9.4.6. Spinal Implants
  • 9.4.7. Neurostimulators
  • 9.4.8. Ophthalmic Implants
  • 9.4.9. Dental Implants
  • 9.4.10. Facial Implants
  • 9.4.11. Breast Implants
• 9.5. Current Market Size (US$ Bn) Forecast by Biomaterial Type, 2024-2031
  • 9.5.1. Metallic Biomaterials
  • 9.5.2. Ceramic Biomaterials
  • 9.5.3. Polymers Biomaterials
  • 9.5.4. Natural Biomaterials
• 9.6. Market Attractiveness Analysis

10. Middle East & Africa Implantable Medical Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
  • 10.2.1. By Country
  • 10.2.2. By Product Type
  • 10.2.3. By Biomaterial Type
• 10.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
  • 10.3.1. GCC Countries
  • 10.3.2. South Africa
  • 10.3.3. Egypt
  • 10.3.4. Nigeria
  • 10.3.5. Rest of Middle East and Africa
• 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Product Type, 2024-2031
  • 10.4.1. Orthopedic Implants
  • 10.4.2. Cardiovascular Implants
  • 10.4.3. Stents
  • 10.4.4. Stent-related Implants
  • 10.4.5. Structural Cardiac Implants
  • 10.4.6. Spinal Implants
  • 10.4.7. Neurostimulators
  • 10.4.8. Ophthalmic Implants
  • 10.4.9. Dental Implants
  • 10.4.10. Facial Implants
  • 10.4.11. Breast Implants
• 10.5. Current Market Size (US$ Bn) Forecast by Biomaterial Type, 2024-2031
  • 10.5.1. Metallic Biomaterials
  • 10.5.2. Ceramic Biomaterials
  • 10.5.3. Polymers Biomaterials
  • 10.5.4. Natural Biomaterials
• 10.6. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping by Market
  • 11.2.2. Competition Dashboard
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Johnson & Johnson Limited
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Abbott Laboratories
  • 11.3.3. Edwards Life-sciences Corporation
  • 11.3.4. Orthofix International N.V.
  • 11.3.5. Novartis International AG
  • 11.3.6. Sorin S.p.A
  • 11.3.7. Boston Scientific Corporation
  • 11.3.8. Smith & Nephew plc
  • 11.3.9. Tornier N.V.
  • 11.3.10. Stryker Corporation

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations